NRXS
Price
$2.60
Change
+$0.20 (+8.33%)
Updated
Nov 19, 04:58 PM (EDT)
Capitalization
25.57M
Intraday BUY SELL Signals
TSHA
Price
$4.00
Change
-$0.15 (-3.61%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.1B
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRXS vs TSHA

Header iconNRXS vs TSHA Comparison
Open Charts NRXS vs TSHABanner chart's image
Neuraxis
Price$2.60
Change+$0.20 (+8.33%)
Volume$100
Capitalization25.57M
Taysha Gene Therapies
Price$4.00
Change-$0.15 (-3.61%)
Volume$98.71K
Capitalization1.1B
NRXS vs TSHA Comparison Chart in %
NRXS
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NRXS vs. TSHA commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NRXS: $2.40 vs. TSHA: $4.14)
Brand notoriety: NRXS and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 13% vs. TSHA: 37%
Market capitalization -- NRXS: $25.57M vs. TSHA: $1.1B
NRXS [@Biotechnology] is valued at $25.57M. TSHA’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than NRXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • NRXS’s TA Score: 4 bullish, 6 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than NRXS.

Price Growth

NRXS (@Biotechnology) experienced а -0.41% price change this week, while TSHA (@Biotechnology) price change was -3.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.1B) has a higher market cap than NRXS($25.6M). TSHA YTD gains are higher at: 131.792 vs. NRXS (8.085). NRXS has higher annual earnings (EBITDA): -7.01M vs. TSHA (-91.48M). TSHA has more cash in the bank: 313M vs. NRXS (5.99M). NRXS has less debt than TSHA: NRXS (410K) vs TSHA (59.6M). TSHA has higher revenues than NRXS: TSHA (8.1M) vs NRXS (3.22M).
NRXSTSHANRXS / TSHA
Capitalization25.6M1.1B2%
EBITDA-7.01M-91.48M8%
Gain YTD8.085131.7926%
P/E RatioN/A2.70-
Revenue3.22M8.1M40%
Total Cash5.99M313M2%
Total Debt410K59.6M1%
TECHNICAL ANALYSIS
Technical Analysis
NRXSTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLW81.691.57
+1.96%
Corning
HWC56.870.15
+0.26%
Hancock Whitney Corp
RCKY29.22-0.01
-0.03%
Rocky Brands
GIC26.74-0.16
-0.59%
Global Industrial Company
RVP0.82-0.01
-0.96%
Retractable Technologies

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+5.83%
CVM - NRXS
58%
Loosely correlated
-7.03%
MRVI - NRXS
26%
Poorly correlated
-3.18%
CTMX - NRXS
25%
Poorly correlated
-0.55%
TSHA - NRXS
24%
Poorly correlated
-3.37%
NGNE - NRXS
24%
Poorly correlated
-1.64%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-3.37%
PCVX - TSHA
45%
Loosely correlated
-1.82%
RGNX - TSHA
41%
Loosely correlated
-2.84%
SLDB - TSHA
38%
Loosely correlated
+0.11%
LXEO - TSHA
38%
Loosely correlated
-0.98%
ERAS - TSHA
37%
Loosely correlated
-3.32%
More